Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss
Balance at beginning of period at Oct. 31, 2020	$ 1,114,828	$ 107,583	$ 1,041,507	$ (34,262)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(28,411)		(28,411)
Issuance of common stock	6,229	350	5,879
Stock-based compensation expense	4,516		4,516
Contribution of shares to a deferred compensation trust	1,485	23	1,462
Purchase of common stock	(32,292)	(343)	(31,949)
Other comprehensive income (loss)	2,086			2,086
Net earnings	111,281		111,281
Balance at end of period at Jan. 29, 2021	1,179,722	107,613	1,104,285	(32,176)
Balance at beginning of period at Oct. 31, 2021	1,151,132	105,206	1,071,922	(25,996)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(31,469)		(31,469)
Issuance of common stock	1,183	109	1,074
Stock-based compensation expense	5,225		5,225
Contribution of shares to a deferred compensation trust	(33)	(33)	0
Purchase of common stock	(76,381)	(753)	(75,628)
Other comprehensive income (loss)	382			382
Net earnings	69,510		69,510
Balance at end of period at Jan. 28, 2022	$ 1,119,549	$ 104,529	$ 1,040,634	$ (25,614)